Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000028

President and CEO acquired 54,180 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-03 Grant or award : show line 1 in the form +54,180 289,987 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-03 Grant or award : show line 2 in the form Stock Option (right to buy) +162,540 162,540 D
Loading xslF345X05/wk-form4_1736294379.xml…